ID drugs

Embed Size (px)

Citation preview

  • 8/12/2019 ID drugs

    1/12

    Key Words : Ototoxicity, Nephrotoxicity or Renal toxicity, Hepatotoxicity, Hematopoietic toxicity, Bactericidal, CYP3A4 Inducer/inhibitor, Cross-react

    Antibacterial ChemotherapyClass Drug Name Mechanism/pharmacokinetics/Resistance Indications Adverse effects

    Inhibitor of Cell Wall Synthesis (ICWS)

    B - L a

    c t a m s P e n i c i l

    l i n s

    M e c h a n i s m

    o f A c t i o n s :

    1 -

    C o v a

    l e n

    t b i n d i n g t o

    t r a n s p e p

    t i d a s e s

    / P B P s

    2 -

    I n h i b i t t r a n s p e p

    t i d a

    t i o n

    r x n

    ( c r o s s - l

    i n k i n g o

    f c e

    l l w a

    l l )

    3 -

    A c

    t i v a

    t i o n o

    f M u r e

    i n h y

    d r o

    l a s e s

    ( a u

    t o l y s

    i n s

    )

    A l l a r e

    b a c

    t e r

    i c i d a

    l ! ! ! !

    Pen G

    Pen V

    Pen G oral/parenteral, Pen V oral; Benzathine depot ; acid labile

    Pen G: particularly for Group B Strep (GBS)

    Gram(+) cocci In general to all penicillin:-Hypersensitivity reaction

    is the major penicillinadverse effect. About 5-8% claim allergic to pens.

    Seizure by high dose penicillins (particularly

    renal failure )

    Nafcillin ,Methicillin ,

    Isoxazolyl penicillins(ox-, clox-)Oxacillin

    Cloxacillin

    Oral; nafcillin and oxacillin parenteral too; ox- clox- and diclox acid-stable

    All B-Lactams: Bactericidal Time dependent .PharmK: poor distribution to eye, prostate, and CNS.

    Anti-Staphyloccocal penicillins

    B-lactamaseresistant!! , Staph.

    aureus

    Carbenicillin indanyl ,Piperacillin ,Ticarcillin ,

    Mezlocillin

    Effective against Proteus , Pseudomonas . Problem: rapid emergencew/Pseudomonas, so use in combo w/ aminoglycosides or

    fluoroquinolones . Note: these are powerful Rx, use only whenindicated to protect their therapeutic value

    Anti-PseudomonalPenicillins

    Ampicillin,Amoxicillin ,

    Increased gram(-) activity Extended SpectrumPenicillins

    Gram +/-

    Ampicillin Rash (10%incidence, 90% in ptx w/

    mononucleosis)

    -Same general contra asabove

    B-Lactamaseinhibitor

    Clavulanic acid ,

    Sulbactam ,Tazobactam

    Resistance to Penicillins by B-lactamase production (major

    mechanism). Use B-lactamase-resistant penicillin (Nafcillin, oxacillin,cloxacillin) + Co-administer w/ B-lactamase inhibitors!

    B-lactamase

    resistant

    Cephalosporins-In general

    Cephalosporins areMore toxic than

    penicillins particularly Renal

    Toxicity Some

    cross-reactivity w/pen-sensitive pts.

    1st generationCephalothin Cephalexin (o)Cefazolin

    Less sensitive to B-lactamase . Broader spectrum of activity.Clinical use: chemoprophylaxis for surgery , alternative to anti-staph

    penicillin.

    (ph)

    Greater gram-activity

    Gram +

    5-10% cross-reactivitywith penicillins.

    Hypersensitivity, some GI,Renal Toxicity ; plateletinhibition and Disulfram

    effect.2nd gen

    Cef uroxime(o)CefotetanCef aclor (o)

    Intermediate Spectrum

    F?

    More gram- than 1 st.Less Gram (+)

    activity

    Cefotetan &cefoperazone: Disulfram

    effect

    3 rd gen

    Broad spectrum. Better for CNS Reserve for Gram-

  • 8/12/2019 ID drugs

    2/12

    Cefotax imeCeftriaxoneCef taz idime

    tax, triax, tazactivity

    4 th genCefepime

    Broad Spectrum. Better distribution (CNS).Cephalosporinase-resistant .

    Reserve for gram- activity

    Mono-bactams(still b-lactams)NEWER DRUGS!

    Aztreonam Gram (-) activity; virtually inactive against Gram (+) or anaerobes.

    Resistant to B-lactamase . No cross-reactivity in pen-sensitive

    patients

    Only good againstGram- activity , B-

    lactam resist

    Carbapenems

    Imipenem Broad spectrum . IV only. Pseudomonas develops resistance rapidly, souse w/ aminoglycosides . Inactivated by renal dipeptidase , co-administer Cilastatin (inhibits enzyme from blocking Imipenem)

    Gram (-/+),anaerobes May Cross-reactivity w/penicillins.

    Meropenem Dipeptidase-resistant carbapenem. So you give this one as a secondline to Imipenem

    May Cross-reactivity w/penicillins.

    Other ICWS

    Non-B-Lactams

    VancomycinBactericidalOtotoxicity

    Renal Toxicity

    Inhibits transglycosylation (step before transpeptidation). Previouslyclassed as too toxic for systemic use. IV drug cleared through kidney enhances oto- & renal toxicity of aminoglycosides. Red man or red

    neck syndrome = histamine release. Misuse/overuse can be aproblem.

    Bactericidal forGram (+).

    Systemic MRSAVancymycin-d

    Nephrotoxic andototoxicity .

    Some thrive on thisdrug!!!: Vancomycin-

    dependent Enterococci Fosfomycin Newest ICWS. Inhibits cell-wall synthesis from within! At the

    cytoplasmic step in cell wall precursor synthesis. Active uptake byglycerophosphate or G6P-transporter. Only oral approved in USA.

    Active drug excreted by kidney. Approved for single-dose therapy ofUTI. Synergistic w/ B-lactams , aminoglycosides , or fluoroquinolones .

    Gram (-) UTI

    Some Gram+ too

    BacitracinBactericidal

    Topical antibiotic only!!!! Markedly nephrotoxic

    Other Polymixin B This agent affects cell membranes. Not sure how. Inhibits G-Polymyxin E Old drug, now used as new drug as last resort. Mech: solubilizes

    bacterial membrane.Anti-Pseudomonal

    How come the class of anti-staph can be used to treat b-lactamase producing pneumococci?

  • 8/12/2019 ID drugs

    3/12

    Class Drug Name Mechanism/pharmacokinetics/Resistance Indications Adverse effects

    Inhibitor of Protein Synthesis (IPS)Aminoglycosides

    Mechanism:irreversible

    inactivation ofribosome

    (30S).

    Irreversible = thinkBactericidal!! !

    OtotoxicityRenal Toxicity

    Streptomycin

    Gentamicin

    Tobramycin

    Amikacin

    BactericidalOtotoxicity

    Renal Toxicity

    Multiple effects on translation misreading of mRNA, interfere w/ initiation , break up polysomes (streptomycin monosomes) PharmK: poor oral absorption usually given IV, sometimes IM.

    Good distribution except for eye and CNS. No significant hostmetabolism. Excretion glomerular filtration. Very high

    concentration in proximal tubule cells!!!!.

    Administer: One Dose a Day at HIGH CONCENTRATION!!!! Once a day gives us a brief time to kill bacteria and gives us the

    rest of the day to relax and avoid the adverse effects: ototoxicity & Nephrotoxicity

    Nephrotoxicity: Exacerbated by Vancomycin, cyclosporine

    Neuromuscular blockade : seen at very high dose phenomenon.Most common during surgery (d/t other NM blockers), also in

    Myasthenia gravis ptx.

    Resistance: emerges rapidly if AG used alone.

    Non-resistant Gram(-) infections: E. coli,

    Proteus,Pseudomonas

    For Pseudomonas :

    use Gent>Tobra>Amika

    Nephrotoxicity!!! : high

    concentrations of AG inrenal cortex. 5-25%receiving AG >3 days

    shows progressive renalimpairment . Ampho B, or

    cisplatinOtotoxicity : high conc ofAG in inner ear. 5-25% of

    ptx. Loss of vestibularand/or auditory fxn. May

    be reversible.Dose- and Time-

    dependent

    Neuromuscular

    Blockade!!!!!!

    Spectinomycin Spectinomycin Related to aminoglycosides. Used againstPenicillin-resistant

    gonococci

    TetracyclinesHepatotoxicity

    Reversible binding to30S subunit.

    Bacteriostatic .

    Tetracycline

    Usually given orally, but absorption variable. Tetracyclines chelatemetal ions : Ca2+, Al3+, Fe2+, Mg2+. Poorly absorbed therefore

    DO NOT administer with food, milk, antacids. Rarely given IV.

    Well distributed, except to CNS, synovial fluid. Concentrates inteeth, bone, liver (bile), kidney .

    Tetracyclines crosses the placenta and are excreted in milk .

    Bacterial resistance to Tetracyclines by:-increased efflux pumps are major resistance .

    -altered ribosomal proteins or RNA are secondary mechanisms.-Especially common in Pseudomonas, proteus

    -indiscriminate use/overuse (clinical & agricultural)

    Broad spectrumantibiotics.

    Gram (+/-)Mycoplasma ,Chlamydia ,Rickettsiae ,

    Lyme disease

    Intracellular bugsincluding

    spirochetes .

    Tick-borne diseases?

    GI direct irritation.Superinfections:

    Pseudomonas, Proteus,Staph, Clostridia, Candida

    Impaired liver function high doses, during

    pregnancy, pre-existingliver dz

    Photosensitization

    Calcium chelation :deposit in teeth & bone leads to discoloration,

    growth retardation,deformity.

    Doxycycline Excreted mostly fecal; others mostly urine

    Glycylcyclines (part Newer generation of tetracyclines. Retain antibacterial spectrum

    Tetracycline

  • 8/12/2019 ID drugs

    4/12

    of Tetracyclines)

    Tigecycline

    of tetracyclines but overcome resistance .

    NOT affected by Efflux pump EXCEPT in Proteus andPseudomonas .

    resistant bacteria!!

    MacrolideAntibiotics

    (older)

    Blocks translocation by binding to 50S

    subunit

    Macrolide Antibiotics (newer)=

    50S

    Erythromycin ,Clarithromycin,Azithromycin

    Clari- and Azi- (broaderspectrum)

    Hepatotoxicity

    Bacteriostatic or bactericidal , depending on dose

    Absorbed from GI tract, but acid-labile. Therefore, we use entericcoating or erythromycin esters to increase stability. Can also beadmin IV. Excellent distribution except to CNS. Crosses placenta.

    Excreted in bile ( 50x higher than in plasma ). Half-life 2-5hrs exceptfor azithromycin (a little longer).

    Resistance: Staph, some strept- and pneumococci. By altered(methylated) rRNA, efflux pump, esterases

    Gram (+),some Gram (-), some

    mycobacteria.

    Think Atypical

    pneumonia !

    Mycoplasma or

    Legionnaires disease, chlamydia

    1. GI distress 2. Microsomal enzymeinhibition (Rx-Rx interx:

    oral anti-coagulants,digoxin, non-sedating anti-

    histamines)3. Hepatotoxicity esp.erythromycin estolate

    cholestatic jaundice!!!! .

    Clarithromycin Higher availability ~Less GI effects

    Azithromycin Minimal P450-based interactions

    Tissue level 10-100x plasma levels!!!T1/2 = 2-4 days.

    Higher availability~Active against mycobacterium avium-intracellulare (MAC) in

    AIDS patients

    Chlamydia

    Active against(MAC) in AIDS

    patients

    High intracellular concentration !!!

    Ketolides(macrolide-like)

    50S

    Telithromycin

    Semi-synthetic macrolide. Oral, well absorbed and distributed.Metabolized in liver, excreted in both bile and urine. Poor

    substrate for efflux pump . ONCE daily dosing !!

    Used for respiratory tract infections (community-acquiredpneumonia, bronchitis, sinusitis). Inhibits CYP3A4

    Doesnt have thatefflux problem

    macrolides have. QT Prolongation!!

    Other Proteinsynthesis inhibitors

    50SChloramphenicol

    Hematopoietictoxicity

    Reversible inhibitor of protein synthesis. Bacteriostatic . Broadspectrum. Well absorbed from all routes, CNS levels = Serum .

    100% excreted in urine (10%filtrate, 90% tubular sec).Glucuronidation in liver is rate-limiting step for

    inactivation/clearance for drug.

    Resistance: key mechanism is plasmid-mediated . Chloramphenicol

    Acyl Transferase (CAT). Slow development. Only slight resistance(2-4x). Ideal drug; however, too many adverse effects.

    Typhoid fever, RockyMountain spotted

    fever in children.

    1) GI disturbances followed by fungal

    superinfections.2) Anemia d/t BM

    depression .3) Aplastic Anemia

    usually irreversible & oftenfatal.

    4) Gray Baby syndrome (poor glucuronidators)

    5) Drug-drug interactions inhibits microsomal

    enzymes.ClindamycinHepatotoxicity

    Lincosamide antibiotic . Bacteriostatic . Well-absorbed anddistributed, except for CNS.

    Bacteroides fragilis,other anaerobes.

    GI upset,Clostridium

  • 8/12/2019 ID drugs

    5/12

    Endocarditisprophylaxis

    superinfection ,

    Hepatotoxicity Other

    Streptogramins :50S

    Newer drugs!

    QuinupristinDalfopristin(Synercid TM)Bactericidal

    Peptide macrolactones. IV, 80% excreted in bile, 20% in urine.POTENT Protein inhibitor of CYP3A4.

    Bacteriostatic against Enterococcus faecium. Bactericidal againstother organisms.

    Approved for use against Vanco- and multi-drug resistantEnterococcus faecium, Methicillin-resistant Staph. Aureus (MRSA).

    VRE, MRSA SERIOUS INDICATIONSHERE FOR DRUG-DRUG

    INTERACTIONS

    OtherOxazolidinones

    Prevents formation of70S ribosomes

    (unique!)

    Linezolid(can inhibit MAOI)

    Bactericidal

    No cross-resistance w/ other IPS. Bactericidal againststreptococci .

    Bacteriostatic against staph and enterococci.IV or oral, Oral AUC = IV AUCGood distribution to tissues.

    Primary: Vanc -resistant E. faecium (Limit to multi-drug

    resistant Gram+infections)

    BM suppression ,Thrombocytopenia (reversible & mild)

    Class Drug Name Mechanism/pharmacokinetics/Resistance Indications Adverse effects

    Inhibitor of Folate Dependent Pathwaysp-Aminobenzoic Acid

    analogs ( PABA)

    Inhibitors of FolateSynthesis

    SulfonamidesHematopoietic toxicity

    Renal Toxicity

    Silver Sulfadiazine PABA analog . Enter into a normal metabolic pathway, butthen blocks that pathway. Competitive inhibitor of

    dihydrofolate synthesis . Biostatic

    Oral, some topical (burns), rarely IV. Well absorbed in GI, welldistributed including CNS. Variable metabolism, depending on

    drug and patient. Acetylation yields inactive metabolite .Excreted in urine (90% by glomerular filtration). 10-20x blood

    concentration in urine.

    Topical application forburns

    Allergic reaction: fever,rash (up to 5% incidence)-May cross react w/ othersulfonamides carbonic

    anhydrase inhibitors,thiazides, furosemide,

    sulfonylureahypoglycemic.

    SodiumSulfacetamide

    Ophthalmic preparations

    Sulfasalazine(not absorbed-split bygut bacteria to release

    aminosalicylate)

    Ulcerative colitis

  • 8/12/2019 ID drugs

    6/12

    Inhibits Pteridinesynthetase UTI uncomplicated, untreated, acute.

    Sulfonamides are now combined with trimethoprim.

    Resistance: mutations overproduction of PABA. Loss ofpermeability. New form of dihydropteroate synthetase

    enzyme can discriminate b/t PABA vs sulfonamide.

    Stevens-Johnsonsyndrome (fever, malaise,

    rare but can be fatal).-Crystalluria/ hematuria -Hematopoietic effects

    -Hemolytic anemias (G6PDH deficiency)

    Inhibitor of Folate use:

    Dihydrofolatereductase (DHFR)

    inhibitors

    Trimethoprim

    Blocks bacterial enzyme. Blocks dihydrofolate reductase . Readily absorbed from GI. Wide distribution including CNS.

    Excreted in urine. Can be used alone for UTI, but usuallycombined w/ sulfonamide (TMP-SMX). Combination is often

    bactericidal.10,000x more effective against bacterial DHFR than againstmammalian enzyme, but still may see anti -folate effects.

    Pneumocystispneumonia, complicated

    UTI.

    Megaloblastic anemia ,

    leukopenia ,

    granulocytopenia . Treat

    w/ folinic acid . (easyfix!)

    CombinationBactrim

    orTrimethoprim-

    Sulfamethoxazole (Co-trimoxazole) aka

    TMP-SMX

    Combo = bactericidal.

    Typical sulfonamideeffects.

    AIDS ptx receiving Co-

    trimoxazole = higherincidence of adverseeffects . Fever, rashes ,leukopenia , diarrhea

    Class Drug Name Mechanism/pharmacokinetics/Resistance Indications Adverse effects

    DNA Gyrase InhibitorQuinolones

    bactericidal

    Nalidixic Acid Prototype quinolone antibiotic.

    Inhibits transcription and DNA replication .Oral admin, rapidly absorbed, rapidly metabolized (glucuronidation),

    and excreted in urine

    Anti-malarial drugs??

    Fluoroquinolones

    Bactericidal!

    Ciprofloxacin Levofloxacin

    Ofloxacin

    Fluorinated analogues of nalidixic acid. Well absorbed & distributedafter oral administration. Only 20% is metabolized (liver). Excreted

    in urine, blocked by probenicid . Effective systemically after oraldose, parenteral forms also available.

    Resistance: altered (mutated) DNA gyrase, especially Pseudomonas ,Staph, Serratia

    Broad-spectrum

    Excellent against Gram-. Useful in GI & UTIs.Shows promise for

    treatment of respiratory,skin, soft tissue

    infections, esp. multi-drug resistant organisms.

    Moderate-good:Gram(+)

    Some GI: nausea,vomiting, diarrhea.

    HA, dizziness, insomnia,abnormal liver fxn tests .

    Blocks theophyllineclearance (cannot be co-admin, duh!). Connective

    tissue dsd?

  • 8/12/2019 ID drugs

    7/12

    Class Drug Name Mechanism/pharmacokinetics/Resistance Indications Adverse effects

    Urinary Tract Antiseptics-Use systemic agents, which are efficiently cleared in the urine: Penicillins, Aminoglycosides, Sulfonamides, Fluoroquinolones.

    Resistance and re-infections are common. May need to suppress bacteria for a long time.Nitrofurantoin Mechanism is unknown, but may involve oxidative stress.

    Bacteriostatic or cidal depends on bug. Rapidly absorbed (oral),metabolized, and excreted in urine (50% as active drug). Even IV does

    not have a systemic effect.

    Resistance: all Pseudomonas , some Proteus

    UTI, Gram+/- ,most effective ifurine pH

  • 8/12/2019 ID drugs

    8/12

    Ethambutol Inhibits synthesis of mycobacterial cell wall glycan (arabinogalactan ?). Well absorbed and distributed. CNS level

    variable, 4-60% of serum. Most excreted in urine accumulates inrenal failure.

    Resistance: rapid, therefore use in combo

    Dose-dependent opticneuritis , decreased acuity ,

    loss of red -green differentiation .

    Streptomycin Was only for severe ( life-threatening ) cases, now used morefrequently. PK.

    adverse effects typical ofaminoglycoside

    IV every day forprophylaxis.. not an ideal

    drug choice!2nd line Anti-TB

    drugsPara-

    aminosalicylate (PAS)

    Currently a resurgence in TB, highly resistant strains are common.2nd line may become 1 st line. Other drugs include: amikacin,

    Ciprofloxacin, OfloxacinCycloserine

    EthionamideSulfone Dapsone Similar to sulfonamide. Well absorbed and distributed.

    Concentrates in skin, muscle, liver, and kidney. Acetylated; excretedin feces and urine.

    Dr. Z: inhibits folic acid synthesis.

    Used in combination w/rifampin and clofazimine

    for M. Leprae . Also may beused for P. jiroveci

    pneumonia.

    Hemolysis andmethemoglobinemia

    common.

  • 8/12/2019 ID drugs

    9/12

    Anti-Fungal ChemotherapyDrug Mechanism/Phamacokinetics Clinical Use Adverse effect

    Class: Systemic Anti-Fungal Agents Amphotericin B ampotherrible drug lotsof side effects

    Binds Ergosterol (essential component of fungal membrane)

    A: IV or intrathecal (into CSF)D: good (except CNS)t 1/2 = 2 weeks (slow)- (side effects dont stop until drug is

    gone).Add to Liposomes drug will have higher affinity to liposomethan to OUR memb lower side effects. Liposome = buffer

    Most important drug for severesystemic mycosesBroad spectrumUse initially then switch (toxic)

    Concentration is greatest:Fungi > liposome > our cell membrane

    Chills, fever, nausea, vomiting,headache

    (premedicate: antipyretics,antihistamines, analgesics)

    Nephrotoxicity

    FlucytosineInhibitor of nucleic acidsynthesis! Anti-cancerdrug.

    Only fungi have cytosinedeaminase!

    Antimetabolite! Fungal cytosine deaminase converts 5-Fluorocytosine to 5-fluorouracil (5-FU)Block DNA & RNA syn

    Use is limited because only some fungi are susceptible andonly given independently = rapid resistance!A: Orally effective,D:widely distributed ( even CNS ),E:urine (10x serum)

    Cryptococcus, some CandidaRapid resistance use w/ AmphotericinB or itraconazole

    Low toxicity

    Anti-Fungal Azoles Azoles all inhibit Ergosterol synthesis (blocks fungal CYP450) Ketoconazole Inhibit Ergosterol synthesis

    A: 1 st oral antifungal for systemic diseaseD: Not into CNS

    Not widely used anymore

    Used as adjunct therapy for prostatecancer (androgen dependent)Systemic fungal diseaseNot used often b/c of side effects.

    GI, hepatotoxicityBlock OUR adrenal steroidogensis

    (Gynecomastia )Alters drug metabolism ofcyclosporine, non-sedating

    antihistaminesItraconazole Inhibit Erogosterol synthesis

    A: Oral and IVHistoplasms, blastomyces, sporothrix Fewer adverse effects than

    ketoconazoleFluconazole Inhibit Erogosterol synthesis

    Water soluble good CSF deliveryMore selective for fungal P450s

    Most widely used. Cryptococcalmeningitis, candidemia,mucocutaneous candidiasis

    Voriconazole Inhibit Erogosterol synthesis . Newest triazoleA: Oral and IV M: liverCleanest/purist drug.

    Aspergillosis, Candida, Dimorphicfungi

    Fewer adverse effects thanketoconazole

    Visual disturbances in 30% ofpatients

    Inhibitors of cell wall synthesisCaspofungin Inhibits synthesis of cell wall b(1-3) glucan

    -Incomplete wall causes lysisLarge cyclic peptide linked to fatty acidIV, highly protein bound, slow metabolism.

    Candida , Emperic anti-fungal(neutrophenia)Salvage therapy for amphotericin-resistant Aspergillus

    Minor GI

  • 8/12/2019 ID drugs

    10/12

    E: Urine, feces

    Anti-fungal agents for mucocutaneous infections Drug Mechanism/Phamacokinetics Clinical Use Adverse effectTopical Nystatin Similar to Amphotericin B Topical antifungal agent

    Can be given orally for intestinal tractToo toxic for systemic use. You

    cannot achieve systemicconcentration safe enough for

    this drug WORST thanamphotericin B!

    Systemic Griseofulvin A: Orally concentrates in keratinized tissue ringworm & athletes foot Terbinafine Similar to Griseofulvin, concentrates in keratinized tissue BUT it does not ACTIVATE until it REACHES TOPICALLOCATION!-Inhibits Squalene epoxidase (ergosterol synthesis)

    More commonly used than

    Anti-Parasitic Chemotherapy

    Drug Mechanism/Phamacokinetics Clinical Use Adverse effectAnti-Malarials

    (Plasmodium falciparum, P. malariae, P. vivax, P. ovale) 1st 2 = single cycle; 2 nd 2 = multiple cycles Chloroquine Alters metabolism of hemoglobin by parasite & blocks nucleic acid

    synthesisA: Oral or parenteral. Rapid, completeD: wideE: urine, 25% as metaboliteGive loading dose for acute tx (long t1/2)Resistance: in SA, Africa, Asia, common in P.falciparum, in P.

    vivax, from P -glycoprotein pumping mechanism

    highly effective blood schizonticide Acute: clears parasitemia from all 4

    plasmodiaCures: P. falciparum & p. malariae

    Use w/ primaquine for P. vivax &ovaleProphylactic of choice : 1 wk before

    travel and continue till 4 wk after

    Well tolerated Pruritis ; GI, mildheadache; may exacerbatepsoriasis or porphyria

    Biggest problem is resistance(efflux pump)

    Block efflux w/verapamil (Ca2+channel blocker-so it has side

    effects)

    Mefloquine UnknownA:oral (to irritating for parenteral) well absorbed,M: liver, excreted in feces

    Prophylaxis or tx of chloroquineresistant

    GI, CNS, possible psychotropic effects (used in murder defenses!)*Nightmares!

    Quinine Inhibits nucleic acid and protein synthesis. Doesnt cross BBB,metabolized by CYP3A4 and CYPs

    Back up for Chloroquine-resistant P.falciparum

    Cinchonism (HA, nausea, sweating,tinnitus, dizziness, blurred vision)

    QT prolongation Atovaquone /

    Proguanil (Malarone)Atovaquone : Inhibits ETC, poor oral absorption, high proteinbinding 2-3 half life.

    Proguanil : inhibits protozoal dihydrofolate reductase, wellabsorbed, half life 12 hrs, extensive metabolism by CYP2C19, activemetabolite is cycloguanil

    Prophylaxis or treatment for P.falciparum resistant.

    GI, HA, anorexia, dizziness

  • 8/12/2019 ID drugs

    11/12

    Fansidar

    (pyrimethamine-sulfadozine)

    Anti-folate combinationBlocks synthesis/utilization of folic acidWell absorbed, excreted in urine

    Use for P. FalciparumSlow acting (Not for acute attacks)

    GI distress, cutaneous rxns

    Steven-Johnson symptoms

    Primaquine This fights protozoans in the LIVER Oral, well absorbed, metabolites are intracellular oxidants

    Tissue Schizonticide (goes after liver)Use in combination w/ chloroquinefor prophylaxis or cure of P. vivax orovale

    Some GI distress, hemolyticanemia in G6PDH deficiency

    Artemisinin Traditional Chinese medicineActivated by oxidative metabolism free radicals, alkylationVery short t 1/2 , oral

    Rapidly acting blood schizonticideFor multi-drug resistant P. Falciparum

    Artesunate Available through CDC only! Cannot get through pharmacy. Used for severe P. falciparum orwhen oral meds cannot be given!

    Other Anti-Protozoal Drugs: Metronidazole

    bactericidal Tissue amebicide, Nitroimidazole (activated by electron donation),effective for anaerobic/hypoxic sites Oral or IV, well absorbed and distributed, including CNS, boneCleared in urine (hepatic metabolism)

    Intestinal, extraintestinal, urogenitalprotozoal infections (Trichomoniasis,Giardiasis, Amebiasis)Anaerobic Infctions (C. Diff)

    Nausea, headache, dry mouth,leucopeniaDisulfram effect (cant drinkalcohol)

    Nitozoxanide Inhibits electron transport system pyruvate ferridoxinoxidoreductase (PFOR).

    Tx: Giardia lamblia andCryptosporidia parvum. Usefulagainst metronidazole-resistantstrains

    Few far better tolerated thanmetronidazole

    Pentamidine UnknownIV, IM or aerosol Concentrates in liver, spleen, kidneysDoesnt enter CNS

    Aerosol: used for tx & prophylaxis forPneumocystis pneumonia

    Respiratory stimulation depression; hypotension, anemiaLess common w/ aerosol

    Anti-HelminthicAnti-Helminthic Chemotherapy

    Mebendazole Blocks microtubule synthesis , blocks vesicle and organellemovementGiven orally,

  • 8/12/2019 ID drugs

    12/12

    Rapidly metabolized, excreted in urineAlbendazole Interferes w/ microtubule aggregation, alters glucose uptake

    Rapidly and completely metabolized in liver, conjugates excreted inurine

    Wide-spec anti-helminthic

    Ivermectin Oral treatment for all intestinal Strongyloidiasis andOnchocercasiasInhibits Cl channel and paralyzes worm and they die!

    Praziquantel Parent is active species membrane permeability to Ca 2+ resulting in contraction andparalysis80% bioavailability from oral dosingRapidly and extensively metabolized, cleared in urine

    Schistosomes, some trematodes andcestodes

    Headache, dizziness, drowsiness

    Diethylcarbamazine(DEC)

    Destroys adult nematodes particularly filarial lymphatic wormsthat causes elephantiasis.

    Drug may have severe side effects.

    Pyrimethamine-SulfonamideClass Drug Name Mechanism/pharmacokinetics/Resistance Indications Adverse effects